Your browser doesn't support javascript.
loading
Remineralizing effect of the association of nano-hydroxyapatite and fluoride in the treatment of initial lesions of the enamel: A systematic review.
Ivette Guanipa Ortiz, Mariángela; Gomes de Oliveira, Simone; de Melo Alencar, Cristiane; Baggio Aguiar, Flávio Henrique; Alves Nunes Leite Lima, Débora.
Afiliação
  • Ivette Guanipa Ortiz M; Department of Restorative Dentistry, Piracicaba Dental School, University of Campinas -UNICAMP, Brazil.
  • Gomes de Oliveira S; Department of Restorative Dentistry, Piracicaba Dental School, University of Campinas -UNICAMP, Brazil.
  • de Melo Alencar C; Department of Dental Materials of the Graduate Program in Dentistry, Federal University of Pará, Belém, PA, Brazil.
  • Baggio Aguiar FH; Department of Restorative Dentistry, Piracicaba Dental School, University of Campinas -UNICAMP, Brazil.
  • Alves Nunes Leite Lima D; Department of Restorative Dentistry, Piracicaba Dental School, University of Campinas -UNICAMP, Brazil. Electronic address: dalima@unicamp.br.
J Dent ; 145: 104973, 2024 06.
Article em En | MEDLINE | ID: mdl-38556192
ABSTRACT

OBJECTIVE:

Assessed the effect of dental products containing nano-hydroxyapatite (nano-HA) + fluoride on the remineralization of white spot lesions (WSL) in vivo or in situ.

METHODS:

Seven databases were explored using a two-pronged approach (intervention/treatment). After screening, full-text assessment, and further exclusion, the qualitative synthesis of five studies (four clinical and one in situ) was performed. Based on the Cochrane collaboration guidelines relevant data of the studies were collected and summarized. The Cochrane risk of bias tool for randomized trials (RoB 2.0) was used to appraise the studies' methodological quality and the GRADE guidelines to assess their level of evidence. The RoB 2.0 domains were rated on their risk of bias (RoB) as low, high, or with some concerns, and an adaptation of the tool was used to the in situ study.

RESULTS:

The included studies assessed 151 WSL in anterior permanent teeth, on patients with varying ages. The protocol application, treatment length (7d-12 w), and control groups varied greatly between the studies making the performance of a quantitative analysis unfeasible. The general RoB of the clinical studies was classified as being of low risk (n = 2) or some concerns (n = 2). The in situ study was considered as being of low risk. The level of the evidence was moderate. Most of the studies found moderate evidence regarding the superiority of this association in clinical settings.

CONCLUSION:

Even with the nano-HA + fluoride promising results for the remineralization treatment of WSL, due to the restricted number of studies and types of products, its extended use cannot be recommended based on the current systematic review, especially when considering the moderate level of the evidence found. CLINICAL

SIGNIFICANCE:

Due to the biocompatibility and higher surface coverage of nano-HA and the remineralization capacity of fluoride formulations, the association of these elements to remineralize WSL has been positively reported. After the collection and qualitative appraise of the data, the clinical evidence of the use of these dental products is promising but limited.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Remineralização Dentária / Cariostáticos / Durapatita / Cárie Dentária / Esmalte Dentário / Fluoretos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Remineralização Dentária / Cariostáticos / Durapatita / Cárie Dentária / Esmalte Dentário / Fluoretos Idioma: En Ano de publicação: 2024 Tipo de documento: Article